BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29510612)

  • 1. PTEN Mutation Identified in Patient Diagnosed with Simultaneous Multiple Cancers.
    Won HS; Chang ED; Na SJ; Whang IY; Lee DS; You SH; Kim YS; Kim JS
    Cancer Res Treat; 2019 Jan; 51(1):402-407. PubMed ID: 29510612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN hamartoma tumor syndromes in childhood: description of two cases and a proposal for follow-up protocol.
    Piccione M; Fragapane T; Antona V; Giachino D; Cupido F; Corsello G
    Am J Med Genet A; 2013 Nov; 161A(11):2902-8. PubMed ID: 24123798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations.
    Sherman SK; Maxwell JE; Qian Q; Bellizzi AM; Braun TA; Iannettoni MD; Darbro BW; Howe JR
    Cancer Genet; 2015; 208(1-2):41-6. PubMed ID: 25554686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN hamartoma tumor syndrome.
    Mester J; Charis E
    Handb Clin Neurol; 2015; 132():129-37. PubMed ID: 26564076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cowden syndrome.
    Gustafson S; Zbuk KM; Scacheri C; Eng C
    Semin Oncol; 2007 Oct; 34(5):428-34. PubMed ID: 17920899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN hamartoma tumor syndrome: an overview.
    Hobert JA; Eng C
    Genet Med; 2009 Oct; 11(10):687-94. PubMed ID: 19668082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer.
    Figer A; Kaplan A; Frydman M; Lev D; Paswell J; Papa MZ; Goldman B; Friedman E
    Clin Genet; 2002 Oct; 62(4):298-302. PubMed ID: 12372056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome.
    Zori RT; Marsh DJ; Graham GE; Marliss EB; Eng C
    Am J Med Genet; 1998 Dec; 80(4):399-402. PubMed ID: 9856571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.
    Marsh DJ; Coulon V; Lunetta KL; Rocca-Serra P; Dahia PL; Zheng Z; Liaw D; Caron S; Duboué B; Lin AY; Richardson AL; Bonnetblanc JM; Bressieux JM; Cabarrot-Moreau A; Chompret A; Demange L; Eeles RA; Yahanda AM; Fearon ER; Fricker JP; Gorlin RJ; Hodgson SV; Huson S; Lacombe D; Eng C
    Hum Mol Genet; 1998 Mar; 7(3):507-15. PubMed ID: 9467011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.
    Marsh DJ; Kum JB; Lunetta KL; Bennett MJ; Gorlin RJ; Ahmed SF; Bodurtha J; Crowe C; Curtis MA; Dasouki M; Dunn T; Feit H; Geraghty MT; Graham JM; Hodgson SV; Hunter A; Korf BR; Manchester D; Miesfeldt S; Murday VA; Nathanson KL; Parisi M; Pober B; Romano C; Eng C
    Hum Mol Genet; 1999 Aug; 8(8):1461-72. PubMed ID: 10400993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol.
    Ngeow J; Eng C
    Methods; 2015 May; 77-78():11-9. PubMed ID: 25461771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel dermatological and skeletal features associated with PTEN variant in PTEN hamartoma tumor syndrome.
    Comeau D; Allain V; Maillet-Lebel N; Ben Amor M
    Eur J Med Genet; 2023 Aug; 66(8):104798. PubMed ID: 37307869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.
    Zhou XP; Waite KA; Pilarski R; Hampel H; Fernandez MJ; Bos C; Dasouki M; Feldman GL; Greenberg LA; Ivanovich J; Matloff E; Patterson A; Pierpont ME; Russo D; Nassif NT; Eng C
    Am J Hum Genet; 2003 Aug; 73(2):404-11. PubMed ID: 12844284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cowden syndrome.
    Farooq A; Walker LJ; Bowling J; Audisio RA
    Cancer Treat Rev; 2010 Dec; 36(8):577-83. PubMed ID: 20580873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
    Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
    PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arteriovenous malformations in Cowden syndrome.
    Turnbull MM; Humeniuk V; Stein B; Suthers GK
    J Med Genet; 2005 Aug; 42(8):e50. PubMed ID: 16061556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity.
    Laury AR; Bongiovanni M; Tille JC; Kozakewich H; Nosé V
    Thyroid; 2011 Feb; 21(2):135-44. PubMed ID: 21190448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria.
    Pilarski R; Burt R; Kohlman W; Pho L; Shannon KM; Swisher E
    J Natl Cancer Inst; 2013 Nov; 105(21):1607-16. PubMed ID: 24136893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome.
    Orloff MS; Eng C
    Oncogene; 2008 Sep; 27(41):5387-97. PubMed ID: 18794875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.